MedPath
HSA Approval

AXCEL EVILINE FORTE SUSPENSION

SIN06400P

AXCEL EVILINE FORTE SUSPENSION

AXCEL EVILINE FORTE SUSPENSION

July 4, 1991

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Therapeutic

General Sale List

Formulation Information

SUSPENSION

ORAL

Medical Information

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

SIMETHICONE

40 mg/5 ml

Simethicone

ALUMINIUM HYDROXIDE (DRIED GEL)

400 mg/5 ml

Aluminum hydroxide

MAGNESIUM HYDROXIDE

400 mg/5 ml

Magnesium hydroxide
© Copyright 2025. All Rights Reserved by MedPath